Literature DB >> 8971880

Psychological and clinical effects of renal biopsy performed using sedation.

K D Blake1, S Madden, B W Taylor, L Rees.   

Abstract

A sedation regimen using sequential oral trinepazine, intravenous Pethco (pethidine, chlorpromazine and promethazine) and diazemuls was evaluated in children having native kidney (n = 17) and transplant kidney (n = 17) biopsies. Biopsy was successful in all cases, with no serious side effects. A self-reported scale of memory recall and pain perception showed the optimal time for biopsy to be between 30 and 90 min after the intravenous Pethco. The child's level of distress was measured by a self-reported scale, a parent-reported scale and an observational scale for doctors and nurses; 45% of children rated themselves highly distressed prior to the procedure, their parents being the best assessors of this distress. Younger children and those undergoing native kidney biopsy had less understanding of the procedure. Children's worries could be clearly categorised into procedural and outcome issues: those undergoing transplant biopsy were more worried about outcome, whereas those undergoing native kidney biopsy were more worried about the procedure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971880     DOI: 10.1007/s004670050190

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  2 in total

1.  Use of propofol for pediatric percutaneous renal needle biopsy: 164 cases of experience.

Authors:  Chen Jie; Lu Kai-Zhi
Journal:  Indian J Pediatr       Date:  2013-01-17       Impact factor: 1.967

2.  International validation of a urinary biomarker panel for identification of active lupus nephritis in children.

Authors:  Eve Mary Dorothy Smith; Andrea Lyn Jorgensen; Angela Midgley; Louise Oni; Beatrice Goilav; Chaim Putterman; Dawn Wahezi; Tamar Rubinstein; Diana Ekdawy; Rachel Corkhill; Caroline Ann Jones; Stephen David Marks; Paul Newland; Clarissa Pilkington; Kjell Tullus; Michael William Beresford
Journal:  Pediatr Nephrol       Date:  2016-09-03       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.